Tarsus Pharmaceuticals, Inc. · 1 day ago
Scientist, Innovation Lab
Tarsus Pharmaceuticals is seeking a skilled and innovative Scientist to join their Innovation Lab team. This role will be instrumental in designing, executing, and analyzing preclinical experiments for internal innovation programs in eye care.
BiopharmaBiotechnologyLife Science
Responsibilities
Execute experimental protocols for various testing methods including phantom model testing, cell/tissue culturing, and ex vivo experimentation
Manage ongoing communications and coordinate activities with external partners (CROs, academic labs) under the strategic guidance of the Sr. Scientist
Coordinate with external partners on in vivo ophthalmology models for efficacy, pharmacokinetics, and toxicity studies
Conduct basic science and clinical literature reviews to support ongoing projects
Analyze and summarize experimental data for internal team meetings and present findings to the Innovation Lab team
Provide scientific opinion and support for cross-functional initiatives as requested
Perform general lab duties, with the potential to take ownership of specific duties as the team expands
Stay current with scientific and medical literature in relevant therapeutic areas
Qualification
Required
PhD in a scientific field required, OR MS with 3+ OR BS with 5+ years life sciences experience
Experience executing preclinical studies, with expertise in in vitro techniques and cell/tissue culture
Strong analytical skills for interpreting complex data, with ability to clearly communicate scientific findings
Self-motivated with the ability to work independently while aligning with strategic objectives
Experience with standard laboratory upkeep and maintenance
Scientific ophthalmology experience
Preferred
Experience working on projects involving external research collaborations
Benefits
Health, dental and vision insurance benefits
Generous paid time off, including vacation, holidays, and personal days
Company
Tarsus Pharmaceuticals, Inc.
Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Funding
Current Stage
Public CompanyTotal Funding
$710.6MKey Investors
Pharmakon AdvisorsVivo Capital
2025-03-12Post Ipo Equity· $125M
2024-04-19Post Ipo Debt· $75M
2024-02-29Post Ipo Equity· $100M
Leadership Team
Recent News
Tarsus Pharmaceuticals, Inc
2025-11-06
Tarsus Pharmaceuticals, Inc
2025-11-05
2025-11-05
Company data provided by crunchbase